Ghosh Subhabrata, Mandi Swati Sen
Division of Plant Biology, Bose Institute, Kolkata, India.
Division of Plant Biology, Bose Institute, Kolkata, India.
Gene. 2015 Jul 25;566(2):184-8. doi: 10.1016/j.gene.2015.04.042. Epub 2015 Apr 17.
Zingiber officinale, medicinally the most important species within Zingiber genus, contains 6-gingerol as the active principle. This compound obtained from rhizomes of Z.officinale, has immense medicinal importance and is used in various herbal drug formulations. Our record of variation in content of this active principle, viz. 6-gingerol, in land races of this drug plant collected from different locations correlated with our Gene expression studies exhibiting high Chalcone Synthase gene (Chalcone Synthase is the rate limiting enzyme of 6-gingerol biosynthesis pathway) expression in high 6-gingerol containing landraces than in the low 6-gingerol containing landraces. Sequencing of Chalcone Synthase cDNA and subsequent multiple sequence alignment revealed seven SNPs between these contrasting genotypes. Converting this nucleotide sequence to amino acid sequence, alteration of two amino acids becomes evident; one amino acid change (asparagine to serine at position 336) is associated with base change (A→G) and another change (serine to leucine at position 142) is associated with the base change (C→T). Since asparagine at position 336 is one of the critical amino acids of the catalytic triad of Chalcone Synthase enzyme, responsible for substrate binding, our study suggests that landraces with a specific amino acid change viz. Asparagine (found in high 6-gingerol containing landraces) to serine causes low 6-gingerol content. This is probably due to a weak enzyme substrate association caused by the absence of asparagine in the catalytic triad. Detailed study of this finding could also help to understand molecular mechanism associated with variation in 6-gingerol content in Z.officinale genotypes and thereby strategies for developing elite genotypes containing high 6-gingerol content.
姜,是姜属中在药用方面最重要的物种,其有效成分是6-姜酚。这种从姜的根茎中提取的化合物具有巨大的药用价值,被用于各种草药配方中。我们对从不同地点收集的这种药用植物地方品种中该活性成分(即6-姜酚)含量变化的记录,与我们的基因表达研究相关,该研究表明,与低6-姜酚含量的地方品种相比,高6-姜酚含量的地方品种中查尔酮合酶基因(查尔酮合酶是6-姜酚生物合成途径的限速酶)表达较高。查尔酮合酶cDNA测序及随后的多序列比对揭示了这些对比基因型之间的7个单核苷酸多态性。将该核苷酸序列转换为氨基酸序列后,明显有两个氨基酸发生了改变;一个氨基酸变化(第336位天冬酰胺变为丝氨酸)与碱基变化(A→G)相关,另一个变化(第142位丝氨酸变为亮氨酸)与碱基变化(C→T)相关。由于第336位的天冬酰胺是查尔酮合酶催化三联体中负责底物结合的关键氨基酸之一,我们的研究表明,具有特定氨基酸变化(即天冬酰胺(存在于高6-姜酚含量的地方品种中)变为丝氨酸)的地方品种会导致6-姜酚含量降低。这可能是由于催化三联体中缺乏天冬酰胺导致酶与底物的结合较弱。对这一发现的详细研究也有助于理解与姜地方品种中6-姜酚含量变化相关的分子机制,从而有助于制定培育高6-姜酚含量优良基因型的策略。